First, CM from BCP-treated hypoxic A549 lung cancer cells were shown to cause a concentration-dependent inhibition of HUVEC tube formation, which was associated with a likewise concentration-dependent decrease in hypoxia-induced VEGF levels. Here, VEGFA is linked to lung cancer.